Results 1 to 10 of about 108,250 (160)

Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence [PDF]

Vaccines, 2023
SARS-CoV-2 vaccination has been the most effective tool to prevent COVID-19, significantly reducing deaths and hospitalizations worldwide. Vaccination has played a huge role in bringing the COVID-19 pandemic under control, even as the inequitable ...
Giuseppe Santoli, Mario Cesare Nurchis, Giovanna Elisa Calabrò, Gianfranco Damiani   +3 more
doaj   +2 more sources

Median-Based Incremental Cost-Effectiveness Ratio (ICER)

Journal of Statistical Theory and Practice, 2012
Cost-effectiveness analysis (CEA) is a type of economic evaluation that examines the costs and health outcomes of alternative strategies and has been extensively applied in health sciences.
Heejung Bang
exaly   +2 more sources

Incremental net benefit of extending human papillomavirus vaccine to boys in oropharyngeal cancer burden: Meta-analysis of cost-effectiveness studies

Journal of Dental Sciences
Background/purpose: The incidence of human papillomavirus (HPV)-related oropharyngeal cancer (OPC) is increasing worldwide. HPV vaccines have shown efficacy in preventing diseases in both males and females.
Adikara Pagan Pratama, Su-Feng Chen, Shih-Chieh Liao, Wei-Chia Su, Jian-Hong Yu   +4 more
doaj   +3 more sources

Decision Rules in Cost-Utility Analysis of Health Technologies

Walailak Journal of Science and Technology, 2021
This review identified 4 distinct decision rules used in the cost-utility analysis of health technologies: threshold incremental cost-effectiveness ratio (ICER), league table, decision making (DM) plane, and linear programming.
Udomsak SAENGOW
doaj   +3 more sources

Universal Dental Adhesives: Cost-Effectiveness and Duration of Use

Applied Sciences, 2022
The purpose of this study was to conduct a cost-effectiveness analysis (CEA) of different brands of universal dental adhesives used for composite restorations.
Ayman A. Banjar, Hani M. Nassar
doaj   +1 more source

Cost‐utility analysis of add‐on dapagliflozin in heart failure with reduced ejection fraction in the Philippines

ESC Heart Failure, 2021
Aim We aim to determine the cost‐effectiveness of dapagliflozin in addition to standard therapy versus standard therapy alone among patients with heart failure with reduced ejection fraction (HFrEF) using the public healthcare provider's perspective in ...
Victor L. Mendoza, Bernadette A. Tumanan‐Mendoza, Felix Eduardo R. Punzalan   +2 more
doaj   +1 more source

How reliable are ICER’s results published in current pharmacoeconomic literature? The controversial issue of price confidentiality

Global & Regional Health Technology Assessment, 2022
Pharmacoeconomic data are widely used along drug life cycle for supporting decision-making processes on research and development, pricing and reimbursement, and market access.
Pierluigi Russo
doaj   +1 more source

Optimal control and cost-effectiveness analysis for dengue fever model with asymptomatic and partial immune individuals

Results in Physics, 2021
Dengue is a vector-borne disease with an increasing incidence worldwide, and it is transmitted by the bites of mosquitoes infected with dengue viruses. This viral infection persistently affects economic sectors and public health.
Joshua Kiddy K. Asamoah, Ernest Yankson, Eric Okyere, Gui-Quan Sun, Zhen Jin, Rashid Jan, Fatmawati   +6 more
doaj   +1 more source

Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures.

Lancet Global Health, 2023
BACKGROUND Assessment of the efficiency of interventions is paramount to achieving equitable health-care systems. One key barrier to the widespread use of economic evaluations in resource allocation decisions is the absence of a widely accepted method to
A. Pichón-Riviere, M. Drummond, A. Palacios, S. García-Martí, F. Augustovski   +4 more
semanticscholar   +1 more source

Cost-Effectiveness Analysis of Myopia Progression Interventions in Children

JAMA Network Open, 2023
Key Points Question What is the most cost-effective strategy for controlling myopia in children? Findings This cost-effectiveness analysis compared 13 myopia progression interventions for children using a Markov model.
S. Agyekum, P. Chan, P. E. Adjei, Yu-Zhou Zhang, Zhao-Hua Huo, Benjamin H. K. Yip, P. Ip, Ian C. K. Wong, Wei Zhang, C. C. Tham, Li-Jia Chen, Xiu J. Zhang, C. Pang, Jason C. S. Yam   +13 more
semanticscholar   +1 more source